Fluzone Trivalent Northern Hemisphere
Product Images NDC 49281-425

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Fluzone Trivalent Northern Hemisphere (NDC 49281-425). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi Vaccines Us Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (5 mL Vial Label)

Principal Display Panel (5 mL Vial Label)
Label for FLUZONE Influenza Vaccine, 5 mL multi-dose vial, 2023-2024 formula. The label includes dose instructions for different age groups and storage conditions. The manufacturer is Sanofi Pasteur Inc., with a US Government License #1725. The label features barcodes and space for lot number and expiration date.*
FDA Label Image

Principal Display Panel (5 mL Vial Package)

Principal Display Panel (5 mL Vial Package)
Packaging label for FLUZONE Influenza Vaccine 15 µg/.5 mL multi-dose vial by Sanofi Vaccines US Inc. The label indicates use for intramuscular injection in individuals 6 months and older, with dosing instructions for different age groups. The box includes storage directions, a barcode, and mentions the 2023-2024 influenza season formula.*
FDA Label Image

Principal Display Panel (0.5 mL Syringe Label)

Principal Display Panel (0.5 mL Syringe Label)
Label for Fluzone Influenza Vaccine, 2023-2024 formula, presented as a 0.5 mL single-dose injection for intramuscular use. It is preservative-free, labeled for prescription use only. Manufacturer is Sanofi Pasteur Inc. The label includes the NDC 49281-312-88 along with placeholders for Lot and Expiration dates and a barcode.*
FDA Label Image

Principal Display Panel (0.5 mL Syringe Package)

Principal Display Panel (0.5 mL Syringe Package)
FLUZONE TRIVALENT NORTHERN HEMISPHERE Influenza Vaccine 2023-2024 Formula packaging label for 10 single-dose prefilled syringes of 0.5 mL each. The vaccine is for intramuscular use in individuals 6 months and older. The label includes storage instructions and manufacturing information by Sanofi Vaccines US Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.